Hosted on MSN1mon
Lupin shares in focus as USFDA inspection at Somerset facility concludes with no observations"Global pharma major ... facility in Somerset, New Jersey. The inspection was carried out from January 28 to February 1, 2025, and concluded with zero 483 observations," the company said in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback